News Sentiment

2196 sentiment intelligence

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 52 Balanced news tone 18 relevant articles
Exchange HKG Hong Kong
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 16.34 Week of 10 Jul 2026
Weighted tone 52/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

87/100 classification confidence.

Company focus 18

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

-1.4% over one week, -0.4% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

ETFs Investing in Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Class H Stocks

Market Reaction

Balanced read

63/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 87/100 classification
One-week reaction -1.4% Price digesting
Trend fit Trend inactive -0.4% over four weeks
Fair value -1.5% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 2
Neutral 16
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 18
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
South China Morning Post 5
Caixin Global 3
TradingView 1
ad-hoc-news.de 1
PR Newswire 1
BioWorld News 1
Fierce Pharma 1
Reuters 1

Event Lens

What the news is about

Classified themes
Market update 14
Analyst action 1
Guidance 1
Deals and strategy 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-18 of 18